{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:00:19Z","timestamp":1791230419841,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cardfail.2025.04.016","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T19:05:31Z","timestamp":1748027131000},"page":"1339-1344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Screening for Undiagnosed Heart Failure: A Viewpoint"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6138","authenticated-orcid":false,"given":"JO\u00c3O PEDRO","family":"FERREIRA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FAIEZ","family":"ZANNAD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2025.04.016_bib0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0002","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0003","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0004","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.553370","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0006","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","author":"Packer","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac306","article-title":"Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled","author":"Ferreira","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0008","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jchf.2024.10.025","article-title":"We need simpler and more integrated guidelines in cardio-kidney-metabolic diseases","volume":"13","author":"Ferreira","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0009","article-title":"Reconsidering the ejection fraction centric view of pharmacologic treatment for heart failure","author":"Ferreira","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"Yusuf","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0011","article-title":"The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial","author":"Cleland","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0012","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1002\/ehf2.15000","article-title":"Heart rate reactivity, recovery, and endurance of the incremental shuttle walk test in patients prone to heart failure","volume":"11","author":"Wei","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0013","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamacardio.2024.0615","article-title":"Reversals in the decline of heart failure mortality in the US, 1999 to 2021","volume":"9","author":"Sayed","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0014","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jchf.2022.06.010","article-title":"Steroidal MRA across the spectrum of renal function: a pooled analysis of RCTs","volume":"10","author":"Ferreira","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0015","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1002\/ehf2.14531","article-title":"Missed opportunities in the diagnosis of heart failure: a real-world assessment","volume":"10","author":"Ferreira","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2020.08.004","article-title":"Estimating the lifetime benefits of treatments for heart failure","author":"Ferreira","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0017","doi-asserted-by":"crossref","DOI":"10.3399\/BJGPO.2021.0006","article-title":"FASTer diagnosis: Time to BEAT heart failure","volume":"5","author":"Taylor","year":"2021","journal-title":"BJGP Open"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0018","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial","volume":"310","author":"Ledwidge","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0019","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.pcad.2020.09.006","article-title":"Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure","volume":"63","author":"Singh","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41591-018-0240-2","article-title":"Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram","volume":"25","author":"Attia","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0021","doi-asserted-by":"crossref","DOI":"10.20344\/amp.22463","article-title":"PRIMARY-HF: Heart failure screening in primary care using point-of-care","author":"Dos Santos","year":"2025","journal-title":"Acta Med Port"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0022","doi-asserted-by":"crossref","first-page":"2258_64","DOI":"10.1038\/s41591-024-03140-1","article-title":"An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score","volume":"30","author":"Reddy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0023","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0024","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0026","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0027","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14740338.2019.1602116","article-title":"An update on the safety of SGLT2 inhibitors","volume":"18","author":"Scheen","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0028","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2215\/CJN.03790322","article-title":"Cost-effectiveness of dapagliflozin as a treatment for chronic kidney disease: a health-economic analysis of DAPA-CKD","volume":"17","author":"McEwan","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2025.04.016_bib0029","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad398","article-title":"Glucagon-like peptide-1 receptor agonists across the spectrum of heart failure","author":"Ferreira","year":"2023","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425002398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425002398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T07:58:03Z","timestamp":1754985483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425002398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1071916425002398"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.04.016","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for Undiagnosed Heart Failure: A Viewpoint","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}